<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Agios Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Agios Pharmaceuticals, Inc.

    Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $542,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jacqualyn Fouse, Ph.D.
    • FOUNDED
      2008
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Anavex Life Sciences Corp.

    Anavex Life Sciences Corp.

    Anavex utilizes precision genetic medicine to treat severe and devastating neurolo...

    Anavex utilizes precision genetic medicine to t...

    Filing Type:    PU
    Pieris Pharmaceuticals, Inc.

    Pieris Pharmaceuticals, Inc.

    Pieris Pharmaceuticals, Inc. is a, clinical-stage biotechnology company committing...

    Pieris Pharmaceuticals, Inc. is a, clinical-sta...

    Filing Type:    PU
    Aevi Genomic Medicine, Inc.

    Aevi Genomic Medicine, Inc.

    Aevi Genomic Medicine is focused on translating genetic discoveries into novel the...

    Aevi Genomic Medicine is focused on translating...

    Filing Type:    PU
    KalVista Pharmaceuticals, Inc.

    KalVista Pharmaceuticals, Inc.

    KalVista is a pharmaceutical company focused on the discovery, development and com...

    KalVista is a pharmaceutical company focused on...

    Filing Type:    PU
    Veru Inc.

    Veru Inc.

    Our strategy is to be known as “the prostate cancer company”. We aspire to be ...

    Our strategy is to be known as “the prostate ...

    Filing Type:    PU
    Madrigal Pharmaceuticals, Inc.

    Madrigal Pharmaceuticals, Inc.

    Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing no...

    Madrigal Pharmaceuticals is a clinical-stage bi...

    Filing Type:    PU
    Biocept, Inc.

    Biocept, Inc.

    Biocept, Inc. is a molecular diagnostics company with commercialized assays for lu...

    Biocept, Inc. is a molecular diagnostics compan...

    Filing Type:    PU
    MorphoSys AG

    MorphoSys AG

    MorphoSys (FSE & NASDAQ: MOR) is a clinical-stage biopharmaceutical company dedica...

    MorphoSys (FSE & NASDAQ: MOR) is a clinical-sta...

    Filing Type:    PU
    Exact Sciences Corporation

    Exact Sciences Corporation

    Exact Sciences Corp. (NASDAQ: EXAS) is committed to playing a role in the eradicat...

    Exact Sciences Corp. (NASDAQ: EXAS) is committe...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.